Eton Pharmaceuticals, Inc. ETON Total debt

Total debt at other companies

HRO

HarrowHROW

$308.37M-32.0%

XER

Xeris Biopharma Holdings, Inc.XERS

$289.44M+12.5%

ANI PharmaceuticalsANIP

$301.48M-4.2%

Zevra Therapeutics, Inc.ZVRA

$1.5M-97.6%

Rigel PharmaceuticalsRIGL

$68.36M+5,079%

Neurocrine BiosciencesNBIX

$463.5M-6.0%

FAQ

What is Eton Pharmaceuticals, Inc.'s total debt?

Eton Pharmaceuticals, Inc. (ETON) reported total debt of $31.26M in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s total debt changed year-over-year?

Eton Pharmaceuticals, Inc.'s total debt increased by 3.7% year-over-year, from $30.16M to $31.26M.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s total debt?

Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total debt has grown at a 32.6% compound annual growth rate (CAGR), from $7.58M to $31.08M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.